Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group
Title:
Rituximab, gemcitabine and oxaliplatin in relapsed or refractory indolent and mantle cell lymphoma: results of a multicenter phase I/II-study of the German Low Grade Lymphoma Study Group
Author:
Scheubeck, Gabriel Hoffmann, Martin Jurinovic, Vindi Fischer, Luca Unterhalt, Michael Schmidt, Christian Böck, Hans-Peter Dührsen, Ulrich Kaesberger, Joachim Kremers, Stephan Lindemann, Hans-Walter Mantovani, Luisa Hiddemann, Wolfgang Hoster, Eva Dreyling, Martin ,